Literature DB >> 29027300

Pattern of in-hospital changes in drug use in the older people from 2010 to 2016.

C Franchi1, I Ardoino2, A Nobili1, L Pasina1, P M Mannucci3, A Marengoni4, F Perticone5.   

Abstract

PURPOSE: To assess the pattern of in-hospital changes in drug use in older patients from 2010 to 2016.
METHODS: People aged 65 years or more acutely hospitalized in those internal medicine and geriatric wards that did continuously participate to the REgistro POliterapie Società Italiana di Medicina Interna register from 2010 to 2016 were selected. Drugs use were categorized as 0 to 1 drug (very low drug use), 2 to 4 drugs (low drug use), 5 to 9 drugs (polypharmacy), and 10 or more drugs (excessive polypharmacy). To assess whether or not prevalence of patients in relation to drug use distribution changed overtime, adjusted prevalence ratios (PRs) was estimated with log-binomial regression models.
RESULTS: Among 2120 patients recruited in 27 wards continuously participating to data collection, 1882 were discharged alive and included in this analysis. The proportion of patients with very low drug use (0-1 drug) at hospital discharge increased overtime, from 2.7% in 2010 to 9.2% in 2016. Results from a log-logistic adjusted model confirmed the increasing PR of these very low drug users overtime (particularly in 2014 vs 2012, PR 1.83 95% CI 1.14-2.95). Moreover, from 2010 to 2016, there was an increasing number of patients who, on polypharmacy at hospital admission, abandoned it at hospital discharge, switching to the very low drug use group.
CONCLUSION: This study shows that in internal medicine and geriatric wards continuously participating to the REgistro POliterapie Società Italiana di Medicina Interna register, the proportion of patients with a very low drug use at hospital discharge increased overtime, thus reducing the therapeutic burden in this at risk population.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  drug use; excessive polypharmacy; internal medicine and geriatric wards; older people; pharmacoepidemiology; polypharmacy

Mesh:

Year:  2017        PMID: 29027300     DOI: 10.1002/pds.4330

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people.

Authors:  C Franchi; P M Mannucci; A Nobili; I Ardoino
Journal:  Eur J Clin Pharmacol       Date:  2019-12-18       Impact factor: 2.953

Review 2.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

3.  Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial.

Authors:  Stefania Antoniazzi; Ilaria Ardoino; Marco Proietti; Valter Monzani; Pier Mannuccio Mannucci; Alessandro Nobili; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2019-07-19       Impact factor: 4.335

4.  Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients.

Authors:  Antonietta Gigante; Marco Proietti; Enrico Petrillo; Pier Mannuccio Mannucci; Alessandro Nobili; Maurizio Muscaritoli
Journal:  Drugs Aging       Date:  2021-12-03       Impact factor: 3.923

5.  Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients.

Authors:  Raffaella Rossio; Sara Mandelli; Ilaria Ardoino; Alessandro Nobili; Flora Peyvandi; Pier Mannuccio Mannucci; Carlotta Franchi
Journal:  Intern Emerg Med       Date:  2022-10-14       Impact factor: 5.472

6.  Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation.

Authors:  Carlotta Franchi; Stefania Antoniazzi; Marco Proietti; Alessandro Nobili; Pier Mannuccio Mannucci
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.